Latest filing published 18 Aug 2026 for Tandem Diabetes Care INC. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of John F. Sheridan across 2 companies, led by Tandem Diabetes Care Inc and Acutus Medical, Inc. Over a trading history stretching from 4 January 2016 to 15 August 2026, the count stands at 42 filings.
Market trades split into 2 purchases (€253k) and 1 sale. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 9 share grants and 30 option exercises.
The latest filing, published on 18 August 2026, reports an option exercise in Tandem Diabetes Care Inc. The clock since the last published purchase (11 August 2025) now reads 433 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 42 declarations